Sept 13th-16th, 2015 June 15th-18th, 2015 April 28th, 2015 March 22-26, 2015 March 9-11, 2015 Dec 3, 2014 Dec 2 and 3, 2014 Nov 19, 2014 Nov 3-5, 2014 Oct 15-17, 2014 Oct 9-12, 2014 Sept 23-25, 2014 Sept 8-13, 2014 June 21-26, 2014 May 28-30, 2014 May 25-27, 2014 March 22,27, 2014 March 9-12, 2014 Nov 28-Dec 1, 2013 November 14-15, 2013 September 24-26, 2013 September 18, 2013 September 17, 2013 September 1-4, 2013 June 12-14, 2013 June 11-12, 2013 June 5-7, 2013 April 22-25,2013 March 22, 2013 March 10-13, 2013 December 3-4, 2012 November 30- December 2, 2013 November 28-29, 2012 November 26-27, 2012 November 20, 2012 September 24-27, 2012 June 17-20, 2012 |
51st Congress of the European Societies of Toxicology | Bridging Sciences for Safety | Porto, Portugal, Meet CapEval Pharma. It will be represented by Company’s managing director, Dr. Olivier Loget. BIO International Convention, Philadelphia, PA, CapEval Pharma will be represented by Company’s managing director, Dr. Olivier Loget where he will meet new clients and put in place new projects. AFSSI, Paris, France, Meet CapEval Pharma. It will be represented by Company’s managing director, Dr. Olivier Loget who will present a communication. 54th Congress of the Society Of Toxicology ,at San Diego, CA, CapEval Pharma was represented by Company’s managing director, Dr. Olivier Loget where he met new clients and put in place new projects. BIO Europe Spring, at Paris, CapEval Pharma was represented by Company’s managing director, Dr. Olivier Loget where he presented a new offers for financing clients projects. At Lille, CapEval Pharma was represented by Company’s managing director, Dr. Olivier Loget at FISE 2014, where he presented a new communication on Scientific Drug Research and Development. At Lille, CapEval Pharma was represented by Company’s managing director, Dr. Olivier Loget at BioFIT 2014, where he presented a new communication on Scientific Drug Research and Development. CapEval at the13th Congress of the International Society of Ocular Toxicology at Kanazawa Bunka Hall, Japan : Capeval’s CEO, one of the Board Director, Dr. Olivier Loget chaired a session on electrophysiology. He has been elected president of the International Society of Ocular Toxicology. CapEval Pharma at MipTec Congress 2014 at the Basel International Congress Centre, Basel, Switzerland. |